ED, Advance Analytics and Precision Health
Novartis
Summary
The Insights and Analytics team is dedicated to enabling improved decision-making at Novartis by leveraging data and advanced analytics capabilities to generate actionable insights that drive business growth. We collaborate closely with the US business, bringing insights and challenging ideas to empower smarter, data-driven decision-making. Reporting into the VP Head, Intelligence & Analytics Capabilities, this role is crucial in advancing the frontiers of personalized healthcare. The role of the ED Advanced Analytics & Precision Health is at the forefront of utilizing EHR, clinical and diagnostic data to uncover patterns and indicators to improve patient identification, enhance treatment efficacy and advance patient outcomes. By effectively communicating complex analytical findings, the individual will drive the company's mission to deliver innovative, personalized treatment solutions that improve patient health.
Job description
Key Responsibilities
- Lead the team responsible for analyzing healthcare data, including clinical trial datasets, transactional claims, and electronic health records.
- Guide the application of established and novel statistical and analytical techniques to support strategic objectives in patient identification, diagnostics utilization, and RWE analytics.
- Develop and lead strategic partnerships with providers to identify eligible patients in their existing patient pools.
- Lead the team in leveraging analysis of provider EHR to inform strategic initiatives and improve patient outcomes.
- Oversee the use of data generated by digital health technologies (DHTs) to capture patient-generated data, electronic patient-reported outcomes (ePROs), and electronic clinical outcome assessments (eCOAs).
- Guide the team in supporting key strategic goals.
- Lead the tracking and analysis of metrics on companion diagnostic availability, offering, and usage.
- Provide the roadmap to enhance diagnostic strategies and improve patient care.
- Lead initiatives that analyze real-world evidence and clinical & diagnostic data to identify patterns and indicators associated with patient response to treatment regimens.
- Focus on strategic insights, especially regarding genetic and biomarker indicators.
- Aligning with NVS stakeholders on research, evidence development, and clinical strategies to drive strategic decision-making, generation of data-driven insights, and the implementation of personalized and precision medicine in healthcare systems.
- Guide the team in conducting the analysis, drafting and reviewing of the relevant sections of technical and study reports, manuscripts for publishing in high-impact peer-reviewed journals, and abstracts and presentations for international conferences.
- Ensure alignment with strategic goals and organizational priorities.
- Communicate complex concepts and interpretations of analysis and findings to diverse audiences, including internal leadership and stakeholders, health economists, clinicians, and health systems.
- Influence decision-making and strategic planning through effective communication.
- Communicate high impact relevant insights on underdiagnosed or undertreated patients to the Patient Finding team.
- Ensure insights are strategically aligned and actionable.
Essential Requirements
- Minimum 10+ years of experience in the pharmaceutical or healthcare industry, with a deep understanding of personalized and precision medicine
- A bachelor’s degree in Medicine, Pharmacology, Epidemiology, Data Science, or a related field; an MBA or advanced degree is preferred
- Minimum 5+ years of domain expertise in these areas are highly desired: Personalized and precision healthcare secondary data analytics, data science, primary market research, field analytics and insights, market access and patient service analytics, or other related strategic analytics and management consulting
- Minimum 5+ years of people management experience.
- Proven track record of enabling data-driven decision-making at a senior leadership level, including addressing complex business challenges and shaping organizational strategy particularly in therapeutic areas
- Proficiency in analyzing healthcare data, including clinical trial datasets and electronic health records, using advanced statistical techniques (e.g., data modelling, time to event analysis)
- Familiarity with digital health tools / technologies and their application in capturing patient-generated data and outcomes
- Experience in working with clinical and diagnostic data to identify genetic and biomarker indicators that influence treatment efficacy
- Ability to draft and review technical reports, manuscripts, and presentations for high-impact scientific publications and conferences
- Excellent communication skills, with the ability to present complex insights and strategies effectively to diverse audiences
- Proven ability to collaborate with healthcare providers, internal stakeholders, and cross-functional teams to align strategies and initiatives
- Strong leadership skills in a team environment which requires negotiation, persuasion, collaboration, and analytical judgment
- Ability to thrive in a fast-paced, dynamic environment and adapt to changing business needs and priorities
Requirements
- Minimum 10+ years of experience in the pharmaceutical or healthcare industry, with a deep understanding of personalized and precision medicine
- A bachelor’s degree in Medicine, Pharmacology, Epidemiology, Data Science, or a related field; an MBA or advanced degree is preferred
- Minimum 5+ years of domain expertise in these areas are highly desired: Personalized and precision healthcare secondary data analytics, data science, primary market research, field analytics and insights, market access and patient service analytics, or other related strategic analytics and management consulting
- Minimum 5+ years of people management experience.
- Proven track record of enabling data-driven decision-making at a senior leadership level, including addressing complex business challenges and shaping organizational strategy particularly in therapeutic areas
- Proficiency in analyzing healthcare data, including clinical trial datasets and electronic health records, using advanced statistical techniques (e.g., data modelling, time to event analysis)
- Familiarity with digital health tools / technologies and their application in capturing patient-generated data and outcomes
- Experience in working with clinical and diagnostic data to identify genetic and biomarker indicators that influence treatment efficacy
- Ability to draft and review technical reports, manuscripts, and presentations for high-impact scientific publications and conferences
- Excellent communication skills, with the ability to present complex insights and strategies effectively to diverse audiences
- Proven ability to collaborate with healthcare providers, internal stakeholders, and cross-functional teams to align strategies and initiatives
- Strong leadership skills in a team environment which requires negotiation, persuasion, collaboration, and analytical judgment
- Ability to thrive in a fast-paced, dynamic environment and adapt to changing business needs and priorities
Benefits
- Health insurance
- Life insurance
- Disability benefits
- 401(k) with company contribution and match
- Paid time off
- Vacation
- Personal days
- Holidays
- Annual equity awards
- Performance-based cash incentive
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.